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Acute lung injury and acute respiratory distress syndrome are clinical entities of multi-factorial origin frequently
seen in traumatically injured patients requiring intensive care. We performed an unsystematic search using PubMed
and the Cochrane Database of Systematic Reviews up to January 2012. The purpose of this article is to review
recent evidence for the pathophysiology and the management of acute lung injury/acute respiratory distress
syndrome in the critically injured patient. Lung protective ventilation remains the most beneficial therapy. Future
trials should compare intervention groups to controls receiving lung protective ventilation, and focus on relevant
outcome measures such as duration of mechanical ventilation, length of intensive care unit stay, and mortality.
Keywords: Lung injury, Acute lung injury (ALI), Acute respiratory distress syndrome (ARDS), Trauma, Injury, Prone
positioning, Extracorporeal membrane oxygenation (ECMO), Rib plating, Rib open reduction internal fixation, Flail
chest, High-frequency oscillatory ventilation (HFOV), Airway pressure release ventilation (APRV)Introduction
The Acute Respiratory Distress Syndrome (ARDS) was
originally described in 1967 by Ashbaugh and Levine [1],
and despite advances in diagnosis and treatment of the
condition over the ensuing forty plus years, it remains a
significant contributing factor to morbidity in the traumat-
ically injured patient [2]. Survivors of ARDS have a lower
functional ability and lower than normal health related
quality of life two years after hospital discharge [3]. The
treatment and rehabilitation of ARDS carries with it a
great societal cost, and thus it remains a disease process of
the utmost importance [4]. This review focuses on ALI
and ARDS in the traumatically injured patient. The
current definitions of acute lung injury (ALI) and acute re-
spiratory distress syndrome (ARDS) stem from the
American-European Consensus Conference, first published
in 1994 [5]. The diagnosis of ALI is a clinical one and
requires the presence of an acute onset, a partial pressure of
arterial oxygen (PaO2) in mm Hg to fraction of inspired
oxygen (FiO2) ratio (P/F ratio) of less than 300 if measured
in mmHg, or less than 40 if measured in kPa, bilateral infil-
trates on chest radiograph, and the lack of evidence of* Correspondence: magdalena.bakowitz@uphs.upenn.edu
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reproduction in any medium, provided the orcardiogenic pulmonary edema or a pulmonary artery oc-
clusion less than or equal to 18 mm Hg or 2.4 kPa. The
definition for ARDS is the same as above, with the excep-
tion that the P/F ratio is less than 200 if measured in mm
Hg (less than 27 if measured in kPa), or less than 150 if
measured in mm Hg (less than 23 if measured in kPa) for
severe ARDS. The definitions have been challenged since
the discovery that higher FiO2 and positive end-expiratory
pressure (PEEP) levels might convert patients who pre-
viously met ARDS criteria to be classified as ALI cases by
P/F ratio, and patients who previously would have been
classified as ALI to carry neither lung injury diagnosis [6,7].Incidence and epidemiology
While sepsis is the most common risk factor for ALI
(representing one third of cases), trauma has been iden-
tified to constitute at least 7% of cases [8]. When first
studied, the incidence of ARDS did not differ between
patients with blunt and penetrating mechanisms of in-
jury, with comparable and declining mortality in both
groups [9]. Over the last decade, mortality rates have
continued to decrease in the general population of
patients with ALI/ARDS [10,11]. The mortality of
trauma-associated ALI is estimated at 24% [8,12,13]. For
trauma patients treated at hospitals participating in
ARDS Network trials, the 60-day mortality rate isal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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decrease in recent years [11]. Ciesla et al. [14] however
reported an encouraging decrease in the progression of
ALI to ARDS and multiple organ failure (MOF) in a
large single center trauma cohort. This must be consid-
ered in light of changing therapies for sepsis, cardiovas-
cular failure, and renal replacement therapies.
A 2002 examination of ALI utilizing data from the
United States showed an estimated 190,000 cases and
74,000 deaths from ALI on a yearly basis [8]. A more re-
cent analysis of the National Trauma Databank shows the
incidence of trauma-related ARDS to be 6.5% of traumat-
ically injured patients requiring mechanical ventilation for
greater than 48 hours [15]. Of patients developing ARDS,
the rate of pneumonia approached 50% with crude mor-
tality of 19%. Patients spent on average 20 days on the
ventilator, 22 days in the intensive care unit (ICU), and
32 days in the hospital. Total charges incurred during
hospitalization were upwards of $244,000 [15].
A 2006 retrospective review of trauma ICU data at the
University of Southern California showed an overall com-
plication rate of 43% in patients with ARDS. Complica-
tions included pneumonia, deep venous thrombosis,
pulmonary embolism, acute renal failure, and dissemi-
nated intravascular coagulopathy. Additionally, ARDS
patients had longer hospital stays than similarly matched
controls, longer ICU stays, and higher hospital charges
($267,037 vs. $136,680) [16]. Despite these differences,
multiple investigators have shown no difference in mortal-
ity between ARDS patients and matched controls [16,17].
A review of blunt traumatic brain injury (TBI) patients
with a head abbreviated injury score (AIS) greater than
or equal to 4 showed a 7.7% incidence of ARDS. The in-
cidence of mortality was similar in TBI patients with
and without ARDS (50% vs. 51.8 %), no significant differ-
ence in regards to discharge functional capacity between
the two groups. Again, patients in the TBI +ARDS group
had more complications (pneumonia, disseminated intra-
vascular coagulation, sepsis), more time spent in the
ICU, and more total hospital days [18].
ARDS following trauma is different in many respects
from ARDS related to other causes. Patients with ARDS
after injury tend to be younger and have fewer comorbid
medical conditions [19]. Endothelial activation factor
levels are lower in patients with ARDS related to trauma
as opposed to septic insults [20-22]. Following cellular
injury, endothelial cells can become activated, a principal
mechanism in the complex pathologic events that result
in ARDS. Although there is no uniform agreement on
the definition of endothelial activation, inflammatory
conditions lead to transcription of mRNA, altered syn-
thesis of proteins, and a change in phenotype or func-
tion in response to stimuli from the environment [23].
Specifically, subgroup analysis of ARDS Network datahas shown significantly lower levels of serum biomarkers
(von Willebrand factor antigen [vWF], surfactant protein
D [SP-D], tumor necrosis factor receptor-1 [TNFr-1],
and intercellular adhesion molecule-1 [ICAM-1], asso-
ciated with poor outcome in trauma patients [19]. More-
over, the mortality of ARDS in victims of trauma is
lower than those with ARDS from other causes after
adjusting for baseline differences [17].
Independent risk factors for the development of ARDS
after blunt trauma are those with an injury severity score
(ISS) > 25, the presence of pulmonary contusion, a large
transfusion requirement, hypotension on admission, and
age > 65 years [24]. Furthermore, investigators have shown
that increasing Acute Physiology and Chronic Health
Evaluation II (APACHE II) scores along with duration of
mechanical ventilation are independent risk factors for the
development of ARDS after trauma [25]. Some have
shown specific injury patterns, such as long bone fracture
and chest injury, to be independently associated [26].
Some have suggested that post-traumatic ARDS comes in
two distinct forms, early (< 48 hours) or late (> 48 hours).
Those developing early ARDS are characterized by a
higher rate of penetrating injury, a lower admission base
deficit, greater 48-hour transfusion requirement, more
fluid administration in the first 5-day period, and a lower
P/F ratio on presentation; namely patients presenting in
hemorrhagic shock. Patients in the late ARDS group
tended to be older and had suffered a bout of pneumonia
during their hospitalization [27]. The mortality rate is
similar between both early and late groups [26,27].
Pathophysiology of ARDS
ARDS is a progressive clinical condition in which the
early phases of the disease are marked by dyspnea and
hypoxemia with the appearance of radiographic infil-
trates on chest radiography [28]. The development of
ARDS is typically secondary to either direct lung injury
(pneumonia, pulmonary contusion, inhalation injury) or
indirect lung injury (overwhelming sepsis, transfusion,
pancreatitis) [28] (Table 1). The clinical picture is a
manifestation of the alveolar degradation and flooding
with protein rich material and cellular debris with subse-
quent increases in pulmonary vascular resistance
(Figure 1) [29]. A complex array of endothelial injury,
Figure 1 The normal alveolus (Left-Hand Side) and the injured alveolus in the acute phase of acute lung injury and the acute
respiratory distress syndrome (Right-Hand Side). Reproduced with permission, fee paid.
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mediated inflammation and injury, oxidant-mediated
injury, ventilator-induced lung injury, and dysregulation
of the coagulation and fibrinolytic pathways are all
implicated in the development of ARDS [28,29]. A pro-
inflammatory milieu emerges in the pulmonary environ-
ment, thus leading to direct parenchymal injury and
clinical deterioration (Figure 2) [29]. Severe traumatic
injury is the epitome of the pro-inflammatory state, and
thus ARDS is seen with increased incidence in thetraumatically injured patient. ARDS may be heteroge-
neous and dependent, or homogeneous and diffuse, as
seen in Figures 3 and 4.
Transfusion practices
Severely injured trauma patients requiring blood transfu-
sion deserve special mention. Evidence clearly illustrates
that early transfusion of packed red blood cells (PRBCs)
is an independent predictor of ARDS and increases with
increasing units of transfused blood [30,31]. Fresh frozen
Figure 2 Mechanisms important in the resolution of acute lung injury and the acute respiratory distress syndrome. Reproduced with
permission, fee paid.
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with a greater risk of developing ARDS, whereas plate-
lets and cryoprecipitate were not [32]. Pre-storage leu-
koreduction has been attempted in an effort to minimizeFigure 3 CT scan of same patient several hours after admission.
Patient had undergone craniotomy for evacuation of intracranial
hemorrhage. Intracranial pressure was not elevated post-operatively.
(Atelectasis and consolidation is heterogeneous at dependent bases).the pro-inflammatory effects of residual leukocyte con-
tamination of stored PRBCs, with the hopes of decreas-
ing post-transfusion ARDS rates. However, randomized
controlled trials have failed to show any difference in the
risk of ALI or ARDS in patients receiving leukoreduced
versus standard PRBCs at 28 days [33].Figure 4 Same patient on hospital day 9, following decannulation
from ECMO. Consolidation is homogeneous and diffuse.
Figure 6 Corresponding admission CXR of 18 year-old female
with severe TBI.
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non-identical plasma has also been explored. No differ-
ence in mortality was noted in the identical versus compat-
ible groups. However, patients receiving ABO-compatible
non-identical plasma had higher complication rates and
significantly higher rates of ARDS and sepsis. Further-
more, the rates of ARDS and sepsis increased as more
units of ABO-compatible non-identical plasma was trans-
fused [34].
Pulmonary contusion
As previously mentioned, pulmonary contusion is an in-
dependent risk factor for the development of ARDS
after trauma [35] and as such much attention has been
paid to quantification of the degree of pulmonary contu-
sion and its ability to alert the physician to future re-
spiratory compromise.
Some have utilized three-dimensional computed tom-
ography in all patients with significant thoracic injury
(Figures 5 and 6). These authors showed that as the pul-
monary contusion percentage exceeded 20% of total lung
parenchyma, a sharp increase in the incidence of ARDS
occurred [35-37]. Some suggest that this could poten-
tially be utilized as a screening tool and enable appropri-
ate lung protective strategies early in the patient’s
course. (See further discussion of pulmonary contusions
under “Treatment”).
Race and gender differences
Longitudinal epidemiologic studies have shown consist-
ent differences in mortality amongst ARDS patients as a
group. Males with ARDS have a persistently higher mor-
tality rate than females with ARDS. Data would also sug-
gest that African-American males with ARDS have a
higher mortality rate than males of other racial back-
grounds. Similarly, females of African-American race
have a higher ARDS mortality rate than females of other
racial backgrounds [22].Figure 5 Admission CT scan of 18 year-old female with severe
TBI (no pulmonary injuries identified).When examining ARDS after traumatic injury, investi-
gators have shown that females are more likely to de-
velop ARDS than their male counterparts. Despite the
higher percentage of ARDS cases in females, the mortal-
ity between female and male patients with ARDS after
traumatic injury does not appear to differ [38]. This data
supports the concept of sex hormones, specifically estro-
gens, having immunologic properties enabling the devel-
opment of lung injury. For both male and female
patients, ARDS increases in incidence with increasing
estradiol levels. Additionally, for both male and female
patients, ARDS declines with increasing testosterone
levels [38]. A recent study by the National Institute of
Health in the United States brought awareness to a po-
tential treatment variability [39]. Women received lung
protective ventilation less frequently than men. However,
after adjustment for height and severity of illness, this
difference was no longer detectable.
Nutrition
The pro-inflammatory environment of the pulmonary
parenchyma in ARDS patients has led some investigators
to examine the effects of enteral nutrition enriched with
fish oils and borage oils containing high levels of antioxi-
dants. Early studies suggested a favorable effect on oxy-
genation, number of ventilator and ICU days, and a
lower incidence of new organ failure [40]. These findings
have been disproven by the recent OMEGA study [41],
which was stopped early for futility. Twice-daily enteral
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antioxidants did not improve the number of ventilator-
free days. Not all patients are able to tolerate enteral
feeds after traumatic injury, thus leading some to exam-
ine the effects of total parenteral nutrition (TPN). Venti-
lated trauma patients receiving TPN were retrospectively
analyzed over a 6-year period. TPN was independently
associated with the development of late ARDS [42].
These data would suggest that the inflammatory modu-
lation properties of the nutritional source be carefully
considered in the patient at risk for ARDS.
Treatment
A number of management strategies relevant to acute
lung injury with an emphasis on prevention of further
deterioration are discussed below (Table 2).
It is common practice to resuscitate the trauma patient
in shock with intravenous fluids even at the expense of
worsening pulmonary edema. A fluid-conservative man-
agement strategy is recommended in the absence of
hypotension or vasopressor requirement based on a
randomized-controlled trial in medical and surgical ICU
patients [43]. While this study did not measure a lower
mortality rate, it also did not increase non-pulmonary
organ failure. Instead, fluid restriction shortened the
duration of mechanical ventilation and the length of in-
tensive care unit stay. No randomized controlled studies
exist that provide sufficient evidence to guide fluid man-
agement specific to the trauma population [44].
Pulmonary contusions can evolve over several days.
Therefore, goals in the initial period are to preventTable 2 A continuum of treatment options with at times inco































Prone positioningatelectasis and derecruitment (as seen in the patient in
Figure 3 and 4). Incentive spirometry and patient
initiated positive airway pressure therapy have been
shown to decrease mechanical ventilator-dependent days,
lengths of stay, infectious morbidity, and mortality in
awake and cooperative patients with rib fractures
assigned to a multidisciplinary pathway [45]. There is no
evidence to draw conclusions on whether recruitment
maneuvers independently reduce mortality or length of
ventilation in patients with ALI or ARDS [46].
A retrospective review of adults with blunt traumatic
pulmonary contusion in an Australian center demon-
strated that noninvasive positive pressure ventilation
(NIPPV) was successfully used to avoid intubation in a set
of trauma patients deemed clinically appropriate despite
severe pulmonary contusions and who met criteria for
ARDS by P/F ratio [47]. Of note, NIPPV was combined
with a multi-modal analgesia regimen including epidural
analgesia, followed by a combination of intravenous
patient-controlled analgesia, non-steroidal anti-inflamma-
tory drugs and acetaminophen. More recently, a small
randomized-controlled trial in patients with thoracic
trauma came to the same conclusion in regard to the use
of NIPPV to avoid intubation [48]. Patients who develop
frank respiratory failure (hypoxia, hypercarbia, increased
work of breathing) should be intubated and mechanically
ventilated without inappropriate delay. Other indications
for intubation are the need for airway protection, combat-
iveness, cardiovascular instability, to facilitate imaging and
procedures, and anticipated pulmonary deterioration. Fol-
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with small volumes and low plateau pressures [49,50],
small tidal volume ventilation and the use of PEEP has
been accepted to maintain alveolar recruitment and oxy-
genation [51]. Borges et al. showed that hypoxemia can be
reversed and the lung fully recruited in early ARDS [52].
A well-designed trial demonstrated that in patients ven-
tilated with low tidal volumes, higher levels of PEEP in
combination with recruitment maneuvers did neither re-
sult in a difference in hospital mortality nor in the rate of
barotrauma when compared to conventional levels of
PEEP [53]. The optimal level of PEEP is still unknown
[54,55]. While PEEP usually aids in recruitment of alveoli,
ventilation/perfusion mismatch can be exacerbated with
ventilator pressures in unilateral lung injury as blood flow
is directed away from the more compliant lung to the
injured lung [56]. Patients with unilateral pulmonary con-
tusions can progress to a clinical picture consistent with
ARDS without meeting the formal criterion of bilateral
infiltrates on chest x-ray for ARDS [5]. Posttraumatic
patients at risk for or who develop ARDS should be venti-
lated with low tidal volumes according to ARDS Network
guidelines as non-traumatized patients are.
High-frequency oscillatory ventilation avoids repeated
opening and closing of lung areas by delivering cycling
pressures above and below a high mean airway pressure
while maintaining lung recruitment and while creating
small tidal volumes of 1-4 ml/kg at a minimum of 60
times per minute (1 Hz). A systematic review and meta-
analysis found that high frequency oscillation ventilation
as an initial ventilation mode for ALI/ARDS suggests a
reduced hospital and 30-day mortality compared to
patients who were treated with conventional mechanical
ventilation, though this evidence is not strong [57].
Airway pressure release ventilation (APRV) is the con-
tinuous administration of positive airway pressure
(CPAP) to achieve recruitment with intermittent airway
pressure releases to allow CO2 clearance. Patients can
breathe at any point while remaining at a higher mean
airway pressures [58]. It is similar to inverse ratio pres-
sure control ventilation (IRV) with the added benefit of
spontaneous breathing, and without the degree of sed-
ation or muscle relaxation necessary for IRV [59]. APRV
is an alternative mode of ventilation in patients with
ALI/ARDS, but has not shown improved outcomes in
mortality in large trials. It has yet to be directly com-
pared to ventilation following the ARDS Network proto-
col. In a recent trial conducted by Roy et al. [60],
Yorkshire pigs sustained ischemia-reperfusion injury by
clamping of the superior mesenteric artery plus induced
peritoneal sepsis. The animals that were immediately
randomized to APRV did not develop ARDS. A major
limitation of this study is that the control group was
ventilated with tidal volumes of 10 ml/kg instead of thecurrent low-volume ventilation standard per ARDSnet
guidelines. The pig study might have had a negative re-
sult, had the researchers used a tidal volume of 6 ml/kg
in their control group.
Neuromuscular blocking agents have been thought to
aid in faster achievement of targeted lung-protective
ventilation settings and patient synchrony with the ven-
tilator. Papazian et al. [61] evaluated the effect of a 2-
day course of neuromuscular blocking agents in patients
who developed severe ARDS requiring intubation within
48 hours of study enrollment. This randomized, double-
blinded trial in 20 multidisciplinary ICUs demonstrated
a trend toward improved adjusted 90-day survival and
increased time off the ventilator, especially in patients
with a PaO2/FiO2 ratio less than 120.
A systematic review of 33 randomized controlled trials
came to the conclusion that the evidence to support
pharmacological interventions, namely prostaglandin E1,
N-acetylcysteine, the early administration of high dose
corticosteroids, or surfactant for ALI and ARDS is insuffi-
cient [62,63].
Intermittent prone positioning therapy can improve
oxygenation, but has failed to show a survival benefit ex-
cept as rescue therapy in the severely hypoxemic ARDS
patient with P/F ratios of less than 100 (if measured in
mm Hg (less than 13 if measured in kPa), but not in
patients with P/F ratios of greater than 100 if measured
in mm Hg (greater than 13 if measured in kPa) [64-66].
Extracorporeal membrane oxygenation (ECMO) has
been used in severe ARDS when the risks of refractory
hypoxemia outweigh the risks of this invasive procedure.
Although an early NIH study showed a greater volume
of blood lost due to systemic coagulation in ECMO
patients and no mortality benefit [67], more recent stud-
ies have demonstrated improved survival with ECMO in
patients following traumatic injury [68,69]. The availabil-
ity of heparin-bonded circuitry can negate the need for
systemic anticoagulation for several days in patients fol-
lowing injury that in the majority of cases is performed
with systemic anticoagulation [70]. Newer, mobile, and
more compact circuits allow for the use of this life-
saving intervention in far-forward military locales and
during military transport [71].
Rib fractures are detected in 10% of trauma admis-
sions. In 6% of patients after blunt chest injury, individ-
ual ribs are fractured in more than one place and allow
paradoxical chest movement with respiration. Surgical
management is controversial despite two level one evi-
dence trials favoring operative fixation [72]. Tanaka
et al. [73] and Granetzny et al. [74] reported signifi-
cantly shorter durations of mechanical ventilation,
length of stay in the ICU, and pneumonia with surgical
fixation. A retrospective study in 1998 by Voggenreiter
[75] had suggested that patients with pulmonary
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much as patients without pulmonary contusions did.
This trend was also observed in a recent retrospective
case-controlled study [76], but did not reach statistical
significance. The controversy is further highlighted by
two reports of improved pulmonary function testing
results after surgical stabilization of flail chest at the
2012 Eastern Association for the Surgery of Trauma
annual scientific meeting [77,78]. Large prospective
randomized-controlled trials are needed for definite
answers to relevant outcome questions.
Conclusions and recommendations
Acute lung injury and acute respiratory distress syn-
drome are heterogeneous diseases, the end result of
many different types of acute pulmonary injury and with
at times overlapping pathogenetic mechanisms [79].
Patients with trauma-associated lung injury have not
received as much investigative attention as their medical
and sepsis-afflicted counterparts with ALI/ARDS. High-
level evidence to recommend ALI/ARDS management
strategies tailored to this particular patient population is
insufficient at this time.
Although there are several management strategies to
improve oxygenation in patients on mechanical ventila-
tion, decisions which therapies to use should be guided
by meaningful outcome measures, including reduced
duration of mechanical ventilation, length of ICU stay,
and mortality [80].
Many trials examining the potential benefits of inter-
ventions have used mechanical ventilation strategies that
are recognized as harmful today. Until recently, too
many studies have failed to compare their intervention
group to controls that reflect the current standard of
care and mitigate progression of the lung injury. At a
minimum, control groups should be ventilated with
small tidal volumes as close to 6 ml/kg predicted body
weight as patient comfort and ventilator synchrony per-
mit, a minimum PEEP of 5 cm H2O, and plateau pres-
sures less than or equal to 30 cm H2O per existing
guidelines for all patients with ALI/ARDS [81]. While
we await future trials, we as clinicians can incorporate
what has been shown to save lives a decade ago: lung
protective ventilation.
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